Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 29 • 04:00PM ET

15.95

-0.18 -1.12 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL RYTM INCY BMRN VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC ITOT TMSL DFAS TMED DFMC BMED TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	11.68%	Shs Outstand	52.57M	Perf Week	-3.92%
Market Cap	838.42M	Forward P/E	-	EPS next Y	-3.15	Insider Trans	-4.93%	Shs Float	46.42M	Perf Month	20.83%
Enterprise Value	758.61M	PEG	-	EPS next Q	-0.62	Inst Own	60.42%	Short Float	13.47%	Perf Quarter	-8.86%
Income	-84.74M	P/S	13973.67	EPS this Y	45.93%	Inst Trans	27.39%	Short Ratio	4.22	Perf Half Y	-16.01%
Sales	0.06M	P/B	5.75	EPS next Y	0.30%	ROA	-71.09%	Short Interest	6.25M	Perf YTD	-12.17%
Book/sh	2.77	P/C	10.21	EPS next 5Y	20.30%	ROE	-88.76%	52W High	24.27 -34.28%	Perf Year	328.76%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	3.58 345.53%	Perf 3Y	-97.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	5.35% 9.59%	Perf 5Y	-99.79%
Dividend TTM	-	EV/Sales	12643.50	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.40	Perf 10Y	-99.78%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	46.30	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	-9.47%	Beta	0.84	Target Price	46.18
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	1.99%	Rel Volume	0.73	Prev Close	16.13
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	4.73%	Avg Volume	1.48M	Price	15.95
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	1,075,507	Change	-1.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)